Citable company snapshot
Labcorp's latest SEC-sourced 2026-03-31 period shows $3.54B in revenue and $277.80M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| xbrl:Revenues | Mar 31, 2026 | $3.54B | $3.52B | +0.6% |
| xbrl:GrossProfit | Mar 31, 2026 | $1.01B | $993.20M | +2.1% |
| xbrl:OperatingIncomeLoss | Mar 31, 2026 | $380.80M | $267.60M | +42.3% |
| xbrl:NetIncomeLoss | Mar 31, 2026 | $277.80M | $164.70M | +68.7% |
| xbrl:NetCashProvidedByUsedInOperatingActivities | Mar 31, 2026 | $191.50M | $614.20M | -68.8% |
| Free Cash Flow (computed) | Mar 31, 2026 | $70.50M | $490.30M | -85.6% |
Source: SEC EDGAR XBRL; period Mar 31, 2026; filed May 4, 2026; accession 0000920148-26-000139.
Continue research
Follow same-sector companies and source explainers connected to the financials view.
A factual guide to free cash flow — how it is built from the cash flow statement, why presentations differ, and how Aerarium Research shows the source.
A factual guide to working capital, current assets, current liabilities, and the operating cash cycle.
A factual guide to stock-based compensation, how it appears in company filings, and why it connects cash flow to share count.
A factual guide to goodwill, intangible assets, acquisitions, and impairment charges in company financial statements.
